Cited by 848Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Obesity, insulin resistance and free fatty acids

Open access
Boden, Guenther·2011·Current Opinion in Endocrinology, Diabetes & Obesity

Abstract

PURPOSE OF REVIEW: To describe the role of free fatty acid (FFA) as a cause for insulin resistance in obese people. RECENT FINDINGS: Elevated plasma FFA levels can account for a large part of insulin resistance in obese patients with type 2 diabetes. Insulin resistance is clinically important because it is closely associated with several diseases including type 2 diabetes, hypertension, dyslipidemia and abnormalities in blood coagulation and fibrinolysis. These disorders are all independent risk factors for cardiovascular disease (heart attacks, strokes and peripheral arterial disease). The mechanisms by which FFA can cause insulin resistance, although not completely known, include generation of lipid metabolites (diacylglycerol), proinflammatory cytokines (TNF-α, IL-1β, IL-6, MCP1) and cellular stress including oxidative and endoplasmic reticulum stress. SUMMARY: Increased plasma FFA levels are an important cause of obesity-associated insulin resistance and cardiovascular disease. Therapeutic application of this knowledge is hampered by the lack of readily accessible methods to measure FFA and by the lack of medications to lower plasma FFA levels.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/med.0b013e3283444b09

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obesity, especially central obesity, is probably the main cause of the metabolic syndrome.

    “Obesity, especially central obesity, is probably the main cause of the metabolic syndrome (MetS)”

    From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [3]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [23]Farese R LeRoith D Taylor SI Olefsky JM Diabetes Mellitus: a Fundamental and Clinical Text 2000 239 251 Lippincott Phiadelphia

Cited by

Sorted by citations

Authors
Boden, G.
Affiliations
Temple University (US)
Corresponding author
Boden, Guenther
Venue
Current Opinion in Endocrinology, Diabetes & Obesity
Published
2011-04
Volume
18
Issue
2
Pages
139-143
ISSN
1752-296X (ISSN-L)
OpenAlex
W2000050828
Cited by
848
References
58
Citations by year
2026: 42 · 2025: 54 · 2024: 60 · 2023: 53 · 2022: 67 · 2021: 65 · 2020: 51 · 2019: 61 · 2018: 52 · 2017: 49 · 2016: 58 · 2015: 59 · 2014: 59 · 2013: 61 · 2012: 43
FWCI
6.56
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Endocrinology Diabetes and Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK58895, R01DK058895)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
free fatty acids, insulin resistance, obesity, type 2 diabetes, cardiovascular disease, diacylglycerol, inflammatory cytokines, oxidative stress, endoplasmic reticulum stress, dyslipidemia, hypertension, fibrinolysis
MeSH terms
Animals, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity, Risk Factors, Up-Regulation, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review